Nilsson O G, Brandt L, Ungerstedt U, Säveland H
Department of Neurosurgery, University of Lund, Lund University Hospital, Sweden.
Neurosurgery. 1999 Nov;45(5):1176-84; discussion 1184-5. doi: 10.1097/00006123-199911000-00032.
Intracerebral microdialysis has been demonstrated to be a useful method for detection of brain ischemia in experimental models and in patients. We have applied new mobile microdialysate analysis equipment that allows a bedside comparison of changes in neurochemistry with the neurological status of the patient. Ten patients with severe aneurysmal subarachnoid hemorrhage (that is, with a high risk of vasospasm and a high risk of subsequent ischemic deficits) were selected.
Microdialysis catheters were inserted into the temporal and subfrontal cortex at the end of aneurysm surgery. Samples, collected hourly for 4 to 11 days, were analyzed immediately at the bedside for glucose, lactate, and glycerol and later for pyruvate and glutamate. The patients' neurological status was monitored constantly, and daily recordings of blood flow velocities were performed using transcranial Doppler sonography.
Concentrations of the measured substances varied widely. Individual analyses revealed that patients with uneventful clinical courses generally demonstrated low and stable levels of the different metabolites, and those with signs of cerebral ischemia demonstrated various patterns of neurochemical changes. Lactate and glutamate seemed to be sensitive markers of impending ischemia, and increased glycerol levels were associated with severe ischemic deficits. Obtaining the microdialysis data directly at the bedside seemed to be of great advantage when relating the values to other clinical findings.
Bedside intracerebral microdialysis monitoring of patients with subarachnoid hemorrhage and signs of delayed ischemia revealed dramatic changes in extracellular concentrations of glucose, lactate, and glycerol that could be directly correlated to the clinical status of the patients. These findings emphasize the potential of microdialysis in neurosurgical intensive care patients.
脑微透析已被证明是在实验模型和患者中检测脑缺血的一种有用方法。我们应用了新的移动微透析液分析设备,该设备可在床边比较神经化学变化与患者的神经状态。选取了10例严重动脉瘤性蛛网膜下腔出血患者(即有血管痉挛高风险和随后发生缺血性缺损高风险的患者)。
在动脉瘤手术结束时,将微透析导管插入颞叶和额叶下皮质。每小时采集样本,持续4至11天,在床边立即分析葡萄糖、乳酸和甘油,随后分析丙酮酸和谷氨酸。持续监测患者的神经状态,并使用经颅多普勒超声每日记录血流速度。
所测物质的浓度差异很大。个体分析显示,临床过程平稳的患者通常表现出不同代谢物水平低且稳定,而有脑缺血迹象的患者表现出各种神经化学变化模式。乳酸和谷氨酸似乎是即将发生缺血的敏感标志物,甘油水平升高与严重缺血性缺损相关。在将微透析数据与其他临床发现相关联时,直接在床边获取微透析数据似乎具有很大优势。
对蛛网膜下腔出血且有延迟缺血迹象的患者进行床边脑微透析监测发现,葡萄糖、乳酸和甘油的细胞外浓度有显著变化,这些变化可直接与患者的临床状态相关。这些发现强调了微透析在神经外科重症监护患者中的潜力。